Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine eGFR discordance
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2024-12 · 44 (12) · 898-906
DOI: 10.1002/phar.4627 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 27.11.2024. Verfasst von Brandy N Hernandez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Cystatin C, Glomerular Filtration Rate, Creatinine, Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NCCIH NIH HHS.
Abstract (Originalsprache)
Background
Accurately estimating glomerular filtration rate (GFR) is crucial for dosing medications in hospitalized patients. Due to limitations of serum creatinine for GFR estimation, serum cystatin C (CysC) has been explored as an alternative functional kidney biomarker. This study assessed discordance between eGFR Cr and eGFR CysC in a large sample of hospitalized patients and examined the frequency of renally eliminated medications affected by eGFR discordance.
Methods
This multisite historical study included adults hospitalized between 2011 and 2023 with CysC and serum creatinine reported within 24 h of each other. The first concurrent biomarker pair for each patient was analyzed. eGFR discordance and use of renally eliminated medications were described.
Results
17,718 hospitalized patients with concurrent creatinine and CysC assessments were included. The median eGFR Cr was 65 mL/min, and the eGFR CysC was 46 mL/min. The median absolute difference of eGFR Cr −eGFR CysC was 15 mL/min, and 7972 patients (45%) had a > 30% absolute difference. There was a significantly greater percentage of patients with an eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Medicine AI and Innovation, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Patrick M Wieruszewski, Jason N Barreto, Erin F Barreto
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- NCCIH NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Hernandez, B. N., Wieruszewski, P. M., Barreto, J. N., Cole, K. C., Damani, S., Kane-Gill, S. L., Kashani, K. B., Kelly, E., Rule, A. D., Teaford, H. R., Zand, J., & Barreto, E. F. (2024). Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine eGFR discordance. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 44(12), 898-906. https://doi.org/10.1002/phar.4627
Vancouver
Hernandez BN, Wieruszewski PM, Barreto JN, Cole KC, Damani S, Kane-Gill SL, et al. Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine eGFR discordance. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2024;44(12):898-906. doi:10.1002/phar.4627
BibTeX
@article{Hernandez2024,
author = {Hernandez, Brandy N and Wieruszewski, Patrick M and Barreto, Jason N and Cole, Kristin C and Damani, Shivam and Kane-Gill, Sandra L and Kashani, Kianoush B and Kelly, Ellen and Rule, Andrew D and Teaford, Hilary R and Zand, Jaleh and Barreto, Erin F},
title = {Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine eGFR discordance},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2024},
volume = {44},
number = {12},
pages = {898--906},
doi = {10.1002/phar.4627}
}
EUVIMED